Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05819086 · ClinicalTrials.gov registry record · NA

Message Testing in Aging African American Smokers

A NA study, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
839
Enrollment target

NCT05819086: Completed NA study, sponsored by University of Wisconsin, Madison.

NCT05819086 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 839 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (40% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05819086, a NA study, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
839 participants
Enrollment target

Study Summary

The goal of this study is to examine different messages to motivate smokers who self-identify as an African American current smoker, between the ages of 50-80 years old to quit smoking. Participants will be asked to complete a survey and look at two messages.

Primary Outcome

Change in participants' motivation to quit pre- and post-viewing of the experimental flyer and video, using a 1 item scaled measurement of motivation to quit (1-7 scale, 7 indicating higher motivation) measured in a single online survey (\~15 minutes).

Interventions

  • BEHAVIORAL Rate Emotional Response
  • BEHAVIORAL Rate Impact of Message

Trial Details

FieldValue
Enrollment Target 839 participants
Start Date 2023-03-13
Est. Completion 2023-03-28
Phase NA
University of Wisconsin, Madison

1,039 total trials

What the finished NCT05819086 record still lists

NCT05819086 is an interventional study that assigns participants to a tested intervention. The registered 839 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (40% lower).

The record links to 0 conditions, and to 2 interventions - of which Rate Emotional Response is the first listed.

NCT05819086 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05819086 about?

NCT05819086 is a clinical study titled "Message Testing in Aging African American Smokers". The goal of this study is to examine different messages to motivate smokers who self-identify as an African American current smoker, between the ages of 50-80 years old to quit smoking. Participants will be asked to complete a survey and look at two messages.

What is the current status of trial NCT05819086?

This trial is currently completed. It is a NA study. The enrollment target is 839 participants. The study started on 2023-03-13. Estimated completion is 2023-03-28.

What interventions are being tested in trial NCT05819086?

The interventions under investigation include: Rate Emotional Response (BEHAVIORAL), Rate Impact of Message (BEHAVIORAL).

Who is sponsoring clinical trial NCT05819086?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05819086's enrollment target sits among peer trials

839 134th of 2000 higher than 1,867 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04831580 · 840 participants · NA

    A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

  • NCT04976881 · 840 participants · NA

    Promoting Preconception Care and Diabetes Self-Management Among Reproductive-Aged Women With Diabetes

  • NCT04985903 · 840 participants · NA

    Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women

  • NCT05384626 · 840 participants · Phase 1

    A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05819086, the US trial registry maintained by the National Library of Medicine. NCT05819086 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.